SUZANNE ALLEY: Open Payments
NPI 1609278845 · ROCKWOOD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,718 in 102 payments from 22 companies in 2025. Trend: 2023 $1,848 · 2024 $1,849 · 2025 $1,718
Food & beverage: $1,718
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $302 |
| PFIZER INC. | 14 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $166 |
| Novo Nordisk Inc | 5 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $100 |
| Abbott Laboratories | 5 | $98 |
| Dexcom, Inc. | 4 | $90 |
| Phathom Pharmaceuticals, Inc. | 6 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| GlaxoSmithKline, LLC. | 4 | $75 |
Products named: CAPLYTA, UBRELVY, ELIQUIS, VRAYLAR, XIFAXAN, FREESTYLE LIBRE 3, Ozempic, Dexcom G6 Transmitter.
Industry payments across TN — which companies pay providers there.
